Pharbinex-pe Tablet, Coated
Product Images NDC 73057-389

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Pharbinex-pe (NDC 73057-389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ulai Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pharbinex Pe Caplet Product Label Image (Pharbinex Pe Caplet Product Label Image)

Pharbinex Pe Caplet Product Label Image (Pharbinex Pe Caplet Product Label Image)
Drug Facts label for Pharbinex-PE tablets, containing Guaifenesin 400 mg and Phenylephrine HCl 10 mg as active ingredients. The label details uses as an expectorant and nasal decongestant, warnings, directions by age group, inactive ingredients, and storage instructions. It also includes contact information and safety precautions regarding use and overdose.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.